title: Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma.
authors: Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum, Germany. n.scola@klinikum-bochum.de.
authors: N
authors: N
authors: Scola
authors: H M
authors: HM
authors: Segert
authors: M
authors: M
authors: Stücker
authors: P
authors: P
authors: Altmeyer
authors: T
authors: T
authors: Gambichler
authors: A
authors: A
authors: Kreuter
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism; D003937:Diagnosis, Differential; D006801:Humans; D007150:Immunohistochemistry; D007636:Keratoacanthoma / Q000378:metabolism* / Q000473:pathology; D019394:Ki-67 Antigen / Q000378:metabolism*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D012878:Skin Neoplasms / Q000378:metabolism* / Q000473:pathology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D050759:Cyclin-Dependent Kinase Inhibitor p21; D019394:Ki-67 Antigen; D018809:Proliferating Cell Nuclear Antigen; D016159:Tumor Suppressor Protein p53